Clinical Trial Update: Calcitriol in the Treatment of Immunoglobulin A Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 study of calcitriol for immunoglobulin A nephropathy is reported, with the trial status currently UNKNOWN. Sponsor: Peking University First Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Immunoglobulin Nephropathy

Drugs mentioned

• Calcitriol (calcitriol)

Snippet

Sponsor: Peking University First Hospital | Conditions: Glomerulonephritis, Autoimmune Diseases | Phase 4 | Status: UNKNOWN